Clinical Study

Testing An Investigational Drug With Standard Treatment Before Surgery For Rectal Cancer

Posted Date: May 15, 2019

  • Investigator: Jordan Kharofa
  • Specialties:
  • Type of Study: Drug

NRG-GI002

Criteria:

To Be Eligible To Participate In This Study, Patients Must Have Rectal Cancer That Is Considered Loc

Keywords:

Cancer, Gi, Nrg-Gi002, Phase Ii, Rectal Cancer

For More Information:

Uc Cancer Institute
513-584-7698
cancer@uchealth.com


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.